Skip to content
Clinical Trials – home

Clascoterone: A New Treatment for Acne and Hair Loss

0 / 1
trials open to patients / all trials
2+
Countries

In short

Clascoterone, a novel topical anti-androgen medication, is currently being studied in several clinical trials for its potential in treating acne vulgaris and androgenetic alopecia (male pattern hair loss). This article summarizes the ongoing research on clascoterone's efficacy, safety, and potential applications in dermatology.

At a glance

Primary Conditions Studied
Acne Vulgaris, Androgenetic Alopecia (Male Pattern Hair Loss)
Formulations
1% cream for acne, 5% solution for hair loss
Application Method
Topical, twice daily
Main Outcome Measures
Acne lesion counts, hair count/coverage, skin barrier function
Safety Monitoring
Skin irritation, dryness, local hormone changes
Additional Studies
Pilonidal sinus disease, skin of color patients
Unique Features
Topical anti-androgen, potentially fewer systemic side effects

What is Clascoterone?

Clascoterone is a new medication that has been developed to treat acne and hair loss. It's also known by its brand name Winlevi. Clascoterone is part of a class of drugs called topical anti-androgens, which means it works by blocking the effects of certain hormones on the skin.

How Does Clascoterone Work?

Clascoterone works by targeting the root causes of acne and hair loss. In acne, it helps to reduce the production of skin oil (sebum) and inflammation. For hair loss, it aims to block the effects of hormones that can cause hair follicles to shrink.

Specifically, clascoterone acts as a sebum inhibitor. Sebum is the oily substance produced by your skin that can contribute to acne when produced in excess. By reducing sebum production, clascoterone helps to prevent the formation of acne.

Conditions Treated by Clascoterone

Clascoterone is primarily used to treat two conditions:

  • Acne Vulgaris: This is the medical term for common acne. Clascoterone cream 1% has been approved for the treatment of acne in patients 12 years and older.
  • Androgenetic Alopecia: Also known as male pattern baldness, this is a common form of hair loss in men. Research is ongoing to determine if clascoterone can effectively treat this condition.

How is Clascoterone Administered?

Clascoterone is typically administered in two forms:

  • Cream: For acne treatment, clascoterone is available as a 1% cream. It's usually applied twice daily to the affected areas of the skin.
  • Solution: For hair loss treatment, clascoterone is being studied as a 5% solution that is applied to the scalp twice daily.

Efficacy of Clascoterone

Several studies are currently underway to evaluate the effectiveness of clascoterone. For acne treatment, researchers are looking at various measures of success, including:

  • Reduction in the number of acne lesions (both inflammatory and non-inflammatory)
  • Improvement in overall acne severity as assessed by doctors
  • Patient-reported improvements in their acne

For hair loss treatment, researchers are examining:

  • Increases in hair count
  • Improvements in hair coverage as reported by patients

Safety and Side Effects

As with any medication, clascoterone may cause side effects. Common side effects observed in studies include:

  • Redness of the skin (erythema)
  • Dryness
  • Peeling
  • Itching (pruritus)
  • Burning or stinging sensation

It's important to note that these side effects are generally mild and tend to improve with continued use of the medication. However, if you experience any severe or persistent side effects, you should consult your healthcare provider.

Ongoing Research

Several clinical trials are currently underway to further investigate the use of clascoterone:

  • Studies are examining the long-term safety and efficacy of clascoterone for acne treatment, including its use in patients with darker skin tones.
  • Researchers are investigating the potential of clascoterone to improve skin barrier function in acne-prone patients.
  • The effectiveness of combining clascoterone with other acne treatments, such as benzoyl peroxide and clindamycin, is being studied.
  • Large-scale trials are underway to evaluate clascoterone's effectiveness in treating male pattern hair loss.

These ongoing studies will help to further our understanding of clascoterone and potentially expand its uses in treating skin and hair conditions.

Questions people often ask

Conditions where Clascoterone is being studied

Each condition opens its own overview and trial list

Trials with Clascoterone

Recruiting trials first

See all 1 →
Quick filters
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.